Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,158.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.464%)
Market Cap: £1.43b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

20 Sep 2011 15:07

RNS Number : 5938O
Genus PLC
20 September 2011
Β 

20 September 2011

Β 

Genus plc

Β 

('Genus' or 'the Company')

Β 

Director/PDMR Shareholding

Β 

Β 

Genus announces that of 117,359 ordinary shares of 10 pence each in the Company ("Ordinary Shares") which vested today in favour of Richard Wood, Chief Executive, under the Genus 2004 Performance Share Plan (the "Plan"), 117,359 Ordinary Shares were today sold on behalf of Richard Wood at a price ofΒ 1,000Β pence per Ordinary Share.

Β 

Richard Wood's direct shareholding in the Company stands atΒ 45,856Β Ordinary Shares which representsΒ 0.08%Β of the issued share capital of the Company which is currentlyΒ 60,239,150 Ordinary Shares.

Β 

Genus also announces that ofΒ 46,927 Ordinary SharesΒ that vested today in favour of Ian Biggs, Head of Global Product & Business Strategy, under the Plan,Β 46,927 Ordinary Shares were today sold on behalf ofΒ Ian BiggsΒ at a price ofΒ 1,000Β pence per Ordinary Share.

Β 

Ian Biggs'Β direct shareholding in the Company stands atΒ 3,375Β Ordinary Shares which representsΒ 0.01%Β of the issued share capital of the Company. In addition, he remains the beneficial owner ofΒ 78,415Β conditional nil-cost optionsΒ under the Plan.

Β 

OfΒ 41,061Β Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer of Europe & The Far East, under the Plan, 31,061 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price ofΒ 1,000Β pence per Ordinary Share.

Β 

Thomas Philip Acton'sΒ direct shareholding in the Company now stands atΒ 31,104Β Ordinary Shares which representsΒ 0.06%Β of the issued share capital of the Company. In addition, he remains the beneficial owner of 78,415Β conditional nil-cost optionsΒ under the Plan.

Β 

Of 28,156 Ordinary Shares that vested today in favour of Ian Farrelly, Group Company Secretary & General Counsel, under the Plan, 28,156 Ordinary Shares were today sold on behalf of Ian Farrelly at a price ofΒ 1,000Β pence per Ordinary Share.

Β 

Ian Farrelly has no direct shareholding in the Company. He remains the beneficial owner of 61,462 conditional nil-cost optionsΒ under the Plan.

Β 

Genus further announces that of 1,619 Ordinary Shares which vested today in favour of Bill Christianson, Chief Operating Officer, The Americas, under the Genus 2004 Executive Share Option Plan (the "ESOP"), 1,619 Ordinary Shares were today sold on behalf of Bill Christianson at a price of 1,000 pence per Ordinary Share.

Β 

Bill Christianson has no direct shareholding in the Company and is the beneficial owner of 56,953 conditional nil-cost options and 18,970 market value share options.

Β 

Of 6,673 Ordinary Shares which vested today in favour of David Crosby, Group Financial Controller, under the ESOP, 6,673 Ordinary Shares were today sold on behalf of David Crosby at a price of 1,000 pence per Ordinary Share.

Β 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 53,843 conditional nil-cost options.

Β 

Β 

For further information please contact:

Β 

Cara Crichton

Assistant Company Secretary

Genus plc

Β 

Tel: 01256 345996

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSURRSRANAKUAR
Date   Source Headline
24th May 20234:54 pmRNSNotification of Major Holdings
18th May 20231:32 pmRNSDirector/PDMR Shareholding
16th May 20236:16 pmRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSTrading Update
9th May 20234:30 pmRNSNotification of Major Holdings
3rd May 20238:44 amRNSTotal Voting Rights
2nd May 20237:00 amRNSShare Award for Incoming CEO
3rd Apr 202311:27 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSAppointment of Chief Executive Officer Designate
21st Mar 20232:58 pmRNSApplication for Block Listing
6th Mar 202312:53 pmRNSNotification of Major Holdings
2nd Mar 20231:51 pmRNSNotification of Major Holdings
1st Mar 20232:20 pmRNSNotification of Major Holdings
24th Feb 20235:13 pmRNSDirector/PDMR Shareholding
24th Feb 202311:39 amRNSNotification of Major Holdings
23rd Feb 20239:33 amRNSReplacement: Interim Results
23rd Feb 20237:00 amRNSChief Executive Officer Retirement
23rd Feb 20237:00 amRNSInterim Results
21st Feb 20235:03 pmRNSNotification of Major Holdings
10th Feb 20232:08 pmRNSNotification of Major Holdings
1st Feb 202310:00 amRNSBlock listing Interim Review
23rd Nov 20221:02 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Trading Update
3rd Nov 20227:00 amRNSRuthin Site Visit
14th Oct 202211:39 amRNSTR-1: Notification of Major Holdings
14th Oct 20227:00 amRNSAnnual Report and Annual General Meeting
15th Sep 202210:55 amRNSNotification of Major Holdings
14th Sep 20224:41 pmRNSDirector/PDMR Shareholding
13th Sep 20226:08 pmRNSDirector/PDMR Shareholding
8th Sep 20221:57 pmRNSNotification of Major Holdings
8th Sep 20227:00 amRNSPreliminary Results
2nd Sep 20229:05 amRNSTotal Voting Rights
2nd Aug 20227:00 amRNSAppointment of Joint Corporate Broker
1st Aug 202210:10 amRNSBlock listing Interim Review
21st Jul 202210:21 amBUSForm 8.3 - Genus Plc - CORRECTION
21st Jul 202210:05 amRNSHolding(s) in Company
20th Jul 20223:03 pmRNSNotification of Major Holdings
19th Jul 202211:57 amBUSForm 8.3 - Genus Plc
5th Jul 20222:10 pmRNSNotification of Major Holdings
1st Jul 20229:35 amRNSTotal Voting Rights
24th Jun 20223:42 pmRNSNotification of Major Holdings
6th Jun 20229:11 amRNSNotification of Major Holdings
1st Jun 202212:45 pmRNSNotification of Major Holdings
30th May 202212:18 pmRNSNotification of Major Holdings
17th May 20229:26 amRNSNotification of Major Holdings
21st Apr 20227:00 amRNSNotification of Major Holdings
19th Apr 20221:50 pmRNSNotification of Major Holdings
31st Mar 20221:34 pmRNSDirector Declaration
28th Mar 20225:36 pmRNSNotification of Major Holdings
8th Mar 20223:47 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.